Sunday, September 20, 2026

ZoomInfo Stock Bearish By 27% In The Last 21 Sessions

ZoomInfo Stock Bearish By 27% In The Last 21 Sessions

ZoomInfo Technologies Inc. (NASDAQ: ZI) is a leading go-to-market intelligence and sales engagement service provider that recently experienced significant market turbulence. The entity saw an astounding 27.08% decline over 21 trading sessions, falling from $0.48 on July 5, 2023, to just.58 as Thursday ended. It's worth noting that this marked three straight sessions of losses for ZoomInfo.

NASDAQ and its relevance to ZoomInfo's performance

This development closely parallels NASDAQ, which experienced a modest decline of 0.12% to close at $956.57 and post its second consecutive session of losses. It's important to mention that ZoomInfo's most recent closing position stood at.40, representing a decrease of 64.52% compared to its 52-week high of.86 which provides a fuller context to the company's performance detractors.

Understanding ZoomInfo's Operational Terrain

ZoomInfo operates across a wide array of verticals - from software, business services and manufacturing to telecom, financial services, retail media & internet, transportation education hospitality & real estate. This not only demonstrates its capacity for resilience and adaptability in ever-evolving market conditions but also shows ZoomInfo's ability to pivot in response to shifting environments.

ZoomInfo's Financial Indicators

ZoomInfo boasts a trailing twelve months (TTM) earnings per share (EPS) of 0.25. Coupled with its price-to-earnings (PE) ratio at 74.32, each dollar of its annual earnings would cost investors $0.32, making this stock more of a growth stock than a value option. However, at only 4.64% for the last twelve months, this firm's modest return on equity (ROE) raises further questions regarding its efficiency at turning shareholder equity into profits.

ZoomInfo's Trading Position

It's significant to note that ZoomInfo continues to trade below its 50-day and 200-day moving averages of.87 and.33 respectively, which suggests further weakness. Indeed, recent performance and market indicators seem to signal an unstable period for ZoomInfo shareholders.

Despite this, market behavior remains unpredictable, and only time will tell whether ZoomInfo's wide operational terrain can help it weather economic fluctuations successfully. Observers and investors should keep a close eye on this space for updates.

More news about ZoomInfo (ZI).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com